Pacira BioSciences (PCRX) Total Liabilities (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Total Liabilities of $554.6 million for Q1 2026, down 29.63% year-over-year from $788.1 million in Q1 2025, and down 3.0% quarter-over-quarter from $571.8 million in Q4 2025.
Pacira BioSciences (PCRX) Total Liabilities (2010 - 2026) Analysis & Trends
Pacira BioSciences' Total Liabilities history runs 17 years deep, the most recent figure standing at $554.6 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 29.63% year-over-year to $554.6 million; the TTM figure through Mar 2026 stood at $554.6 million (down 29.63% YoY), while the FY2025 annual figure was $571.8 million, down 26.23% from the prior year.
- Total Liabilities for Q1 2026 stood at $554.6 million, down from $571.8 million in the prior quarter.
- The five-year high for Total Liabilities was $1.2 billion in Q1 2022, with the low at $554.6 million in Q1 2026.
- The 5-year median for Total Liabilities is $767.5 million (2024), against an average of $776.3 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 85.62% in 2022, then slumped 36.09% in 2023.
- Pacira BioSciences' Total Liabilities stood at $906.2 million in 2022, then declined by 22.28% to $704.3 million in 2023, then gained by 10.07% to $775.2 million in 2024, then decreased by 26.23% to $571.8 million in 2025, then slipped by 3.0% to $554.6 million in 2026.
- Business Quant data shows PCRX's Total Liabilities at $554.6 million in Q1 2026, $571.8 million in Q4 2025, and $570.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Pacira BioSciences | 945.90 Mn | 694.87 Mn | 148.24 Mn | 572.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 572.00 Mn |
| Mar 31, 2026 | 554.64 Mn |
| Dec 31, 2025 | 571.81 Mn |
| Sep 30, 2025 | 570.36 Mn |
| Jun 30, 2025 | 779.50 Mn |
| Mar 31, 2025 | 788.13 Mn |
| Dec 31, 2024 | 775.17 Mn |
| Sep 30, 2024 | 772.11 Mn |
| Jun 30, 2024 | 767.54 Mn |
| Mar 31, 2024 | 691.16 Mn |
| Dec 31, 2023 | 704.26 Mn |
| Sep 30, 2023 | 702.91 Mn |
| Jun 30, 2023 | 734.41 Mn |
| Mar 31, 2023 | 755.38 Mn |
| Dec 31, 2022 | 906.19 Mn |
| Sep 30, 2022 | 964.24 Mn |
| Jun 30, 2022 | 977.35 Mn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.34 Bn |
| Sep 30, 2021 | 637.40 Mn |